Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/23744235.2018.1558369 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of rifampicin-colistin combination against XDR Acinetobacter baumannii harbouring bla-like gene and showed reduced susceptibility to colistin at Cairo University Hospital, Cairo, Egypt.
Infect Dis (Lond)
April 2019
c Department of Microbiology and Immunology, Faculty of Pharmacy , Ahram Canadian University, Giza , Egypt.
[Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
Mikrobiyol Bul
April 2018
Hacettepe University Faculty of Medicine, Department Infectious Diseases and Clinical Microbiology, Ankara, Turkey.
Carbapenem resistant Acinetobacter baumannii is a bacterium that causes various hospital acquired infections, primarily ventilator-associated pneumonia and bloodstream infections. The multidrug resistance problem of the bacteria all over the world, is also a problem in our center. As the treatment options are decreasing combination therapies become a current issue.
View Article and Find Full Text PDFPolymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
J Antimicrob Chemother
January 2017
Infectious Diseases Unit, Rambam Medical Center, Haifa, Israel.
Objectives: The objective of this study was to summarize available data on polymyxin-based combination therapy or monotherapy for carbapenem-resistant Gram-negative bacteria.
Methods: This is a systematic review. We included observational studies and randomized controlled trials (RCTs) comparing polymyxin monotherapy versus polymyxin-based combination therapy in adult patients with infections caused by carbapenem-resistant or carbapenemase-producing Gram-negative bacteria.
In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations.
Infect Chemother
March 2015
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Background: Multi-drug resistant (MDR) Acinetobacter baumannii has emerged as one of the most important nosocomial pathogens. In addition to the diverse resistance mechanisms, some A. baumannii strains are known to have biofilm-producing capacity, thereby decreasing antibiotic effectiveness.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!